Literature DB >> 16279799

Irreversible inactivation of trypanothione reductase by unsaturated Mannich bases: a divinyl ketone as key intermediate.

Brittany Lee1, Holger Bauer, Johannes Melchers, Thomas Ruppert, Lauren Rattray, Vanessa Yardley, Elisabeth Davioud-Charvet, R Luise Krauth-Siegel.   

Abstract

Trypanothione reductase is a flavoenzyme unique to trypanosomatid parasites. Here we show that unsaturated Mannich bases irreversibly inactivate trypanothione reductase from Trypanosoma cruzi, the causative agent of Chagas' disease. The inhibitory potency of the compounds strongly increased upon storage of the DMSO stock solutions. HPLC, NMR, and mass spectrometry data of potential intermediates revealed a divinyl ketone as the active compound inactivating the enzyme. ESI- and MALDI-TOF mass spectrometry of trypanothione reductase modified by the Mannich base or the divinyl ketone showed specific alkylation of the active site Cys52 by a 5-(2'chlorophenyl)-3-oxo-4-pentenyl substituent. The reaction mechanism and the site of alkylation differ from those in Plasmodium falciparum thioredoxin reductase where the C-terminal redox active dithiol is modified. After deamination, unsaturated Mannich bases are highly reactive in polycondensation with trypanothione. Interaction of these compounds with both trypanothione and trypanothione reductase could account for their potent trypanocidal effect against Trypanosoma brucei.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16279799     DOI: 10.1021/jm0504860

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

Review 1.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

2.  Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography.

Authors:  Stephen Patterson; Magnus S Alphey; Deuan C Jones; Emma J Shanks; Ian P Street; Julie A Frearson; Paul G Wyatt; Ian H Gilbert; Alan H Fairlamb
Journal:  J Med Chem       Date:  2011-09-01       Impact factor: 7.446

3.  Trypanothione reductase: a viable chemotherapeutic target for antitrypanosomal and antileishmanial drug design.

Authors:  M Omar F Khan
Journal:  Drug Target Insights       Date:  2007-06-19

4.  Synthesis, hematological, biochemical, and neurotoxicity screening of some mannich base hydrochlorides.

Authors:  Karima Lahbib; Iyadh Aouani; Hafedh Abdelmelek; Soufiane Touil
Journal:  Toxicol Int       Date:  2013-09

Review 5.  Advances in preclinical approaches to Chagas disease drug discovery.

Authors:  Fernando Villalta; Girish Rachakonda
Journal:  Expert Opin Drug Discov       Date:  2019-08-14       Impact factor: 6.098

6.  Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections.

Authors:  Liwen Feng; Sébastien Pomel; Perle Latre de Late; Alexandre Taravaud; Philippe M Loiseau; Louis Maes; Fidelis Cho-Ngwa; Christina A Bulman; Chelsea Fischer; Judy A Sakanari; Peter D Ziniel; David L Williams; Elisabeth Davioud-Charvet
Journal:  Molecules       Date:  2020-11-01       Impact factor: 4.411

7.  Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target.

Authors:  Angela N Kuntz; Elisabeth Davioud-Charvet; Ahmed A Sayed; Lindsay L Califf; Jean Dessolin; Elias S J Arnér; David L Williams
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069

8.  Natural Sesquiterpene Lactones of the 4,15-iso-Atriplicolide Type are Inhibitors of Trypanothione Reductase.

Authors:  Mairin Lenz; R Luise Krauth-Siegel; Thomas J Schmidt
Journal:  Molecules       Date:  2019-10-16       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.